Statistics

Total Visits

Views
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as a biomarker for the effect of PTK787/ZK 222584 as second-line mono-therapy in patients with stage IIIB or stage IV non-small-cell lung cancer (NSCLC). 144

Total Visits per Month

October 2014 November 2014 December 2014 January 2015 February 2015 March 2015 April 2015
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as a biomarker for the effect of PTK787/ZK 222584 as second-line mono-therapy in patients with stage IIIB or stage IV non-small-cell lung cancer (NSCLC). 4 11 2 2 4 4 0

File Downloads

Views
dce-mri abstract.pdf 12

Top Country Views

Views
United States 58
Canada 15
China 9
Russia 9
United Kingdom 6
Netherlands 4
South Korea 3
Sweden 2
Germany 1
Hong Kong 1

Top City Views

Views
Miami Beach 22
Toronto 12
Santa Clara 6
Zhengzhou 6
Kansas City 5
Beijing 2
Lethbridge 2
Nynäs 2
Seoul 2
Weston-super-mare 2